The slip
PARKINSON RECEIPTno. 1890
18 Oct 2026, 08:59 UTCdopamine neurons, braak
predictionPPM1D in dopamine neurons tracks Braak Lewy-body stage
registered2f3a981643f28fbc
discovery-0.29 p=0.443 n=9
replication-0.02 p=0.965 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.29, p 0.443)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTdedf6dfe3adaef3d2a165d0d…
follows 61c001db94d7…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1890: PPM1D in dopamine neurons, braak
- power
- full sample -0.19 (p 0.439, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.21 (p 0.403, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.22 (p 0.384, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.10, sign flips 0; without severely affected donors -0.19 (p 0.439, n 18). fragile.
- cell type
- strongest in OPCs: -0.67 (p 0.0024, n 18) vs -0.19 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PPM1D in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PPM1D · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.00 p 1.000 (needs p < 8.3e-4)